Wellspect HealthCare joins the National Climate Initiative within the Healthcare and Life Science Sector in Sweden

Mölndal, Sweden – February 3, 2026 – A broad public–private partnership is now being launched to accelerate the green transition within the Swedish healthcare and life science sector. The initiative aims, through collaboration, to reduce greenhouse gas emissions with the ambition of reaching net zero across the entire value chain by 2045.

The partners of the national climate initiative for the healthcare sector commit to reducing their emissions through time-bound transition plans aligned with the Paris Agreement. This will be achieved through innovations, circular business models and material flows, as well as preventive health measures and more efficient treatments. Initially, the focus is on preventive care and circular solutions.

“The industry and other stakeholders are taking the lead to strengthen Sweden’s competitiveness. Together, we are demonstrating that a climate-neutral healthcare and life science sector is possible—while safeguarding patient safety and public health,” says Sara Modig, State Secretary to Minister for Energy and Business, Ebba Busch.

The work also builds on Sweden’s Life Science Strategy, which highlights the need for increased efforts to strengthen competitiveness and innovation through climate transition and reduced environmental impact.

“We are proud to take part in this initiative, which aligns with our long-term ambition to reach net-zero emissions by 2045,” says Chris Schlenk, Group Vice President, Wellspect HealthCare. “It reflects our commitment to addressing the challenges facing our planet, while keeping our focus on the needs of people living with chronic continence conditions. By sharing goals with the organizations representing the people who rely on our solutions and patient groups across Swedish healthcare, this partnership gives us a strong opportunity to jointly advance the transition toward a more climate‑neutral healthcare sector.

The healthcare sector plays a crucial role in modern societies by alleviating suffering, curing disease and saving lives through informed clinical decisions. At the same time, it accounts for five percent of global greenhouse gas emissions, according to the 2023 report Countdown on Health and Climate Change published by The Lancet.

The climate impact of healthcare is distributed as follows:

• 50% supply chains
• 5% research and development
• 35% healthcare operations and hospital logistics
• 10% patients

Companies and organizations joining the initiative commit to having quality-assured climate targets, for example through the Science Based Targets initiative (SBTi). Current participants in the national climate initiative for the healthcare sector include:

Apotea

Apoteket

Apotek Hjärtat

AstraZeneca

DOZ Apotek

Kronans Apotek

Läkemedelsindustriföreningen (Lif)

Mölnlycke Health Care

Novo Nordisk

Region Skåne

Region Stockholm

SwedenBIO

Swedish Medtech

Swedish Pharmacy Association

Tamro

Västra Götalandsregionen

Wellspect HealthCare

Supporting partners:

Swedish Medical Products Agency

RISE (coordinator)

Life Science Office (Government Offices of Sweden)

To learn more about the National Climate Initiative, please visit:  

Climate Initiative for Swedish Health Care and Life Science sector | RISE

For more details, please contact:

Marion Par-Weixlberger | Vice President Public Relations, Corporate Communications & Brand
Sirona Straße 1 | 5071 Wals bei Salzburg | Austria 

T +43 (0) 662 2450-588 | F +43 (0) 662 2450-540 

publicrelations@dentsplysirona.com

About Wellspect

Wellspect HealthCare, a subsidiary of Dentsply Sirona, is a leading global provider of innovative medical devices dedicated to improving the quality of life for individuals with bladder and bowel dysfunction.

With approximately 1,200 employees worldwide, Wellspect is committed to making a real difference for people managing continence care needs, empowering them to live each day to the fullest.

Wellspect delivers solutions that support safe bladder and bowel management, and continuously enhances the user experience, clinical performance, and service quality for healthcare professionals and users alike.

As one of the world’s leading manufacturers of intermittent urinary catheters, Wellspect has been at the forefront of innovation since 1983 with its LoFric® brand, which introduced the first hydrophilic-coated catheter.

Wellspect has also pioneered the development of Navina™, an innovative transanal irrigation system designed to support individuals living with chronic bowel disorders.

Every day, Wellspect strives to maintain the highest quality standards while minimizing the environmental impact of its products.

Headquartered in Mölndal, Sweden, Wellspect operates in more than 40 countries, offering life-enhancing solutions to people around the world. Dentsply Sirona, the world’s largest diversified manufacturer of professional dental products and technologies, is listed on Nasdaq under the symbol XRAY.